Caribbean Medical Journal



Appendix 2. Risk of bias assessment and grade of evidence of included studiesAuthors/year (country)Study design Random sequence generationAllocation concealmentBlinding of participants and personnelBlinding of outcome assessmentIncomplete outcome data addressed (attrition bias) Selective reporting bias Risk of bias(High, Moderate, Low)Grade of evidence (Very low, Low, Moderate, High)CHLOROQUINEPaton et al, 2011 (Singapore)RCT YesYes YesYes YesNoLowHighMillán-O?ate et al, 2020 (Columbia)Case reportNo No No No YesNo High Very lowBorba et al, 2020 (Brazil)RCTYesYesYesYesYesNoLowHigh HYDROXYCHLOROQUINEChen et al, 2020 (China)Open-label, parallel-groupYes No NoNoYes NoHigh Low Gautret et al, 2020 (France)Open-label, non-randomizedNoNoNoNoYesNoHigh Low LOPINAVIR/RITONAVIR (LPV/r)Lim et al, 2020. (China)Case reportNo No No No Yes No High Very low Deng et al, 2020 (China)Retrospective NoNoNoNoYes NoHigh LowLiu et al, 2020 (China)Case series No NoNo No YesNo High Very low Cao et al, 2020 (China)Open-label RCT Yes Yes No NoYes NoLowModerateRIBAVIRIN AND INTERFERONZhao et al, 2003 (China)Retrospective No NoNoNoYesNoHigh LowAl Tawfiq et al, 2014 (Saudi Arabia)Case seriesNo No No No YesNo High Very low Arabi YM et al, 2019 (Saudi Arabia) RetrospectiveNo No No No Yes No High Low CORTICOSTEROIDSMoreno et al, 2018 (Spain)ProspectiveNo No No No Yes No Low-Moderate Low-Moderate Cao et al, 2016 (China)Case-control No No No No Yes No Low-Moderate Low-Moderate Diaz et al, 2012 (Spain)Prospective No NoNoNo Yes No Low-Moderate Low-Moderate Brun-Buisson et al, 2011 (France)RetrospectiveNo No No No Yes No Low-Moderate Low-Moderate Delaney et al/2016 (Canada)ObservationalNo No No No Yes No Low-Moderate Low-Moderate Li et al/ 2017 (China)Retrospective No No NoNoYes No Low-Moderate Low-Moderate Alfaraj et al, 2019 (Saudi Arabia)RetrospectiveNo NoNoNoYes No Low-ModerateLow-Moderate Arabi et al/2018 (Saudi Arabia)Retrospective No No No No Yes NoLow-Moderate Low-Moderate Xing et al/2019 (China)Case-control No No No No Yes No Low-Moderate Low-Moderate Auyeung et al, 2005 (China) RetrospectiveNo NoNoNoYesNo High Low Yam et al, 2007 (Hong Kong)RetrospectiveNo No No No Yes No High Low Li et al, 2004 (China) RetrospectiveNo No No No Yes No High Low Zha et al, 2020 (China)ObservationalNo No No No Yes No High LowTOCILIZUMAB (TCZ)Michot et al, 2020 (France)Case report NoNoNoNoYesNoHigh Very low Zhang et al, 2020 (China)Case reportNoNoNoNo Yes No High Very low Luo et al, 2020 (China) Case series No No NoNoYes NoHigh Low Xu et al, 2020 (China)Retrospective No No No No Yes No High Low-Moderate UMIFENOVIR (ARBIDOL)Deng L et al, / 2020 (China)Retrospective NoNoNoNoYes NoHigh LowWang et al, 2020 (China)Retrospective No No No No Yes No High Low Lian et al, 2020 (China)Retrospective No No No NoYes No High-Moderate Low-ModerateZhu et al, 2020 (China)RetrospectiveNoNo No No Yes No High Low FAVIPIRAVIR (FPV)Cai et al, 2020 (China)Open-label,non-randomizedNo No NoNoYes No High Low Chen et al, 2020 (China)Open-label, randomized. Yes No No No Yes No High-Moderate Low ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download